Patent No. EP2550286 (titled "Crystalline Forms Of A Macrolide, And Uses Therefor") was filed by Cempra Pharmaceuticals on Mar 22, 2011. The application was issued on Dec 9, 2015.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| LEK PHARMACEUTICALS DD | Sep 9, 2016 | HERZOG |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Feb 22, 2022
Feb 9, 2022
Feb 9, 2022
Feb 9, 2022
Feb 5, 2022
Feb 5, 2022
Jan 27, 2022
Jan 26, 2022
Jan 26, 2022
Jan 25, 2022
Jan 21, 2022
Jan 19, 2022
Jan 19, 2022
Jan 19, 2022
Oct 19, 2021
Oct 19, 2021
Aug 26, 2021
Mar 8, 2021
Mar 4, 2021
Mar 4, 2021
Mar 1, 2021
Mar 1, 2021
Feb 19, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Feb 14, 2019
Nov 22, 2018
Oct 8, 2018
Oct 4, 2018
Oct 1, 2018
Oct 1, 2018
Sep 27, 2018
Sep 27, 2018
Sep 27, 2018
Sep 27, 2018
Sep 27, 2018
Sep 27, 2018
Sep 27, 2018
Sep 27, 2018
Sep 27, 2018
Aug 3, 2018
Aug 3, 2018
Jul 30, 2018
Jul 27, 2018
Jul 27, 2018
Jul 27, 2018
May 25, 2018
May 22, 2018
May 18, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
May 17, 2018
Mar 8, 2018
Mar 2, 2018
Mar 1, 2018
Mar 1, 2018
Mar 1, 2018
Mar 1, 2018
Mar 1, 2018
Mar 1, 2018
Mar 1, 2018
Mar 1, 2018
Mar 1, 2018
Feb 27, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Feb 26, 2018
Jan 9, 2018
Jan 2, 2018
Jan 2, 2018
Jan 2, 2018
Jan 2, 2018
Jan 2, 2018
Jan 2, 2018
Jan 2, 2018
Jan 2, 2018
Dec 22, 2017
Dec 22, 2017
Dec 22, 2017
Aug 8, 2017
Aug 2, 2017
Aug 2, 2017
Jul 28, 2017
Jul 27, 2017
Jul 27, 2017
Jul 27, 2017
Jul 27, 2017
Jul 27, 2017
Jul 27, 2017
Jul 27, 2017
May 18, 2017
May 10, 2017
May 10, 2017
May 10, 2017
May 10, 2017
Apr 24, 2017
Apr 11, 2017
Mar 1, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Oct 18, 2016
Oct 18, 2016
Sep 27, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Sep 9, 2016
Dec 9, 2015
Nov 12, 2015
Oct 13, 2015
Oct 13, 2015
Oct 13, 2015
Oct 13, 2015
Oct 13, 2015
Jul 16, 2015
Jul 8, 2015
Jul 8, 2015
Jul 8, 2015
Jun 12, 2015
Jun 12, 2015
Jun 12, 2015
Jun 12, 2015
Jun 12, 2015
Oct 27, 2014
Oct 27, 2014
Oct 27, 2014
Oct 27, 2014
Jun 26, 2014
Jun 26, 2014
May 20, 2014
May 20, 2014
May 20, 2014
May 20, 2014
May 15, 2014
May 9, 2014
May 9, 2014
May 9, 2014
Feb 13, 2014
Feb 12, 2014
Feb 6, 2014
Feb 6, 2014
Feb 6, 2014
Jan 10, 2014
Jan 10, 2014
Jan 3, 2014
Nov 12, 2013
Nov 12, 2013
Nov 12, 2013
Nov 12, 2013
Nov 12, 2013
Sep 17, 2013
Aug 30, 2013
Aug 30, 2013
Aug 30, 2013
Aug 22, 2013
May 10, 2013
May 10, 2013
May 10, 2013
May 10, 2013
May 9, 2013
May 9, 2013
May 9, 2013
May 9, 2013
May 9, 2013
Jan 4, 2013
Oct 30, 2012
Oct 26, 2012
Oct 10, 2012
Sep 25, 2012
Sep 25, 2012
Aug 3, 2012
Oct 18, 2011
Sep 29, 2011
Sep 29, 2011